Peer navigation for smoking cessation in smokers with HIV: Protocol for a randomized clinical trial

被引:4
|
作者
Cioe, Patricia A. [1 ]
Pinkston, Megan [2 ,3 ]
Tashima, Karen T. [4 ]
Kahler, Christopher W. [1 ]
机构
[1] Brown Univ, Ctr Alcohol & Addict Studies, Sch Publ Hlth, Dept Behav & Social Sci, Box G-S121-4, Providence, RI 02912 USA
[2] Brown Univ, Warren Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA
[3] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA
[4] Brown Univ, Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA
关键词
Smoking; Smoking cessation; HIV; Peer navigation; CIGARETTE-SMOKING; LIFE EXPECTANCY; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; MEDICATION ADHERENCE; SOCIAL SUPPORT; CANCER BURDEN; USE DISORDERS; LUNG-CANCER; TOBACCO USE;
D O I
10.1016/j.cct.2021.106435
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Smoking prevalence in persons with HIV (PWH) is high (40%) and cessation rates remain low. Lack of social support and poor adherence to nicotine replacement therapy (NRT) are related to poor cessation outcomes; thus, both factors represent possible targets for smoking cessation interventions. Peer navigators (PNs) have been integrated into HIV care with great success to improve engagement and adherence to antiretroviral therapy. However, no clinical trial has evaluated the potential for PNs to provide social support and improve NRT adherence for smoking cessation. We developed a treatment protocol that targets social support, adherence, and self-efficacy for quitting by incorporating PNs into a smoking cessation program. This randomized trial will test whether this approach results in higher rates of 7-day point prevalence abstinence at 12-and 24-weeks, compared to standard treatment. Methods: Seventy-two smokers with HIV will be randomized to either Peer Navigation Social Support for smoking cessation (PNSS-S) or standard cessation counseling. All participants will meet with a nurse for a smoking cessation counseling session, which will include discussion of FDA-approved cessation pharmacotherapy. Participants assigned to PNSS-S will receive weekly phone calls from the PN for 12 weeks. The PN will address readiness to quit, using medication to quit, common barriers to cessation, high risk situations, slip management, and maintaining abstinence. Smoking cessation outcomes will be measured at 4, 12, and 24 weeks following the baseline appointment. Conclusion: Results from this study will provide preliminary evidence of whether incorporating a peer navigator based intervention into smoking cessation treatment can improve smoking cessation outcomes in PWH.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Peer Navigation for Smoking Cessation in People With HIV Who Smoke: A Pilot Randomized Controlled Trial
    Cioe, Patricia A.
    Pinkston, Megan
    Stang, Garrett S.
    Tashima, Karen T.
    Kahler, Christopher W.
    NICOTINE & TOBACCO RESEARCH, 2024,
  • [2] An Integrated mHealth App for Smoking Cessation in Black Smokers With HIV: Protocol for a Randomized Controlled Trial
    Bizier, Andre
    Jones, Arielle
    Businelle, Michael
    Kezbers, Krista
    Hoeppner, Bettina B.
    Giordano, Thomas P.
    Thai, Jessica M.
    Charles, Jacqueline
    Montgomery, Audrey
    Gallagher, Matthew W.
    Cheney, Marshall K.
    Zvolensky, Michael
    Garey, Lorra
    JMIR RESEARCH PROTOCOLS, 2024, 13
  • [3] A Randomized Clinical Trial of the Efficacy of Extended Smoking Cessation Treatment for Adolescent Smokers
    Bailey, Steffani R.
    Hagen, Sarah A.
    Jeffery, Christina J.
    Harrison, Christopher T.
    Ammerman, Seth
    Bryson, Susan W.
    Killen, Diana T.
    Robinson, Thomas N.
    Killen, Joel D.
    NICOTINE & TOBACCO RESEARCH, 2013, 15 (10) : 1655 - 1662
  • [4] An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial
    Businelle, Michael S.
    Garey, Lorra
    Gallagher, Matthew W.
    Hebert, Emily T.
    Vujanovic, Anka
    Alexander, Adam
    Kezbers, Krista
    Matoska, Cameron
    Robison, Jillian
    Montgomery, Audrey
    Zvolensky, Michael J.
    JMIR RESEARCH PROTOCOLS, 2022, 11 (05):
  • [5] RETENTION OF HOMELESS SMOKERS IN A SMOKING CESSATION CLINICAL TRIAL
    Okuyemi, K.
    Richards, C.
    Sharif, F.
    Eischen, S.
    Thomas, J.
    Wang, Q.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2016, 23 : S145 - S146
  • [6] Varenicline for smoking cessation among methadone-maintained smokers: A randomized clinical trial
    Stein, M. D.
    Caviness, C. M.
    Kurth, M. E.
    Audet, D.
    Olson, J.
    Anderson, B. J.
    DRUG AND ALCOHOL DEPENDENCE, 2013, 133 (02) : 486 - 493
  • [7] The efficacy of the combination of sertraline with buspirone for smoking cessation - A randomized clinical trial in nondepressed smokers
    Carrao, Jorge Luiz
    Moreira, Leila Beltrami
    Fuchs, Flavio Danni
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (07) : 383 - 388
  • [8] A Randomized Controlled Trial of a Tailored Group Smoking Cessation Intervention for HIV-Infected Smokers
    Moadel, Alyson B.
    Bernstein, Steven L.
    Mermelstein, Robin J.
    Arnsten, Julia H.
    Dolce, Eileen H.
    Shuter, Jonathan
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (02) : 208 - 215
  • [9] Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial
    Yammine, Luba
    Kosten, Thomas R.
    Cinciripini, Paul M.
    Green, Charles E.
    Meininger, Janet C.
    Minnix, Jennifer A.
    Newton, Thomas F.
    MEDICINE, 2018, 97 (02)
  • [10] A Randomized Clinical Trial of Smoking Cessation Treatments Provided in HIV Clinical Care Settings
    Humfleet, Gary L.
    Hall, Sharon M.
    Delucchi, Kevin L.
    Dilley, James W.
    NICOTINE & TOBACCO RESEARCH, 2013, 15 (08) : 1436 - 1445